ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 054,33
-1,07%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Achieve Life Sciences Inc (ACHV)

  7. Achieve Life Sciences Inc (ACHV) Actualités

ACHV Achieve Life Sciences Inc

4,70
0,125 (2,73%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Achieve Life Sciences Inc ACHV NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,125 2,73% 4,70 22:52:38
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,57 4,48 4,64 4,61 4,575
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202414:00GLOBEAchieve Life Sciences to Announce First Quarter Financial..
11/4/202414:00GLOBEAchieve Life Sciences to Present at Life Science Innovation..
28/3/202421:01GLOBEAchieve Life Sciences Reports Financial Results for Fourth..
20/3/202413:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline ORCA..
14/3/202413:00GLOBEAchieve Life Sciences to Announce Fourth Quarter and..
06/3/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:41EDGAR2Form 8-K - Current report
29/2/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202414:01GLOBEAchieve Life Sciences Reaches Agreement with the FDA on..
29/2/202414:00GLOBEAchieve Life Sciences Announces Pricing of up to $124.2..
27/2/202421:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202420:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:04EDGAR2Form 8-K - Current report
09/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:00GLOBEAchieve Life Sciences Reports Financial Results for Third..
26/10/202314:00GLOBEAchieve Life Sciences to Announce Third Quarter 2023..
03/10/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
11/9/202314:00GLOBEAchieve Life Sciences Announces Presentation of..
07/9/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
14/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:06EDGAR2Form 8-K - Current report
14/8/202322:00GLOBEAchieve Life Sciences Reports Financial Results for Second..
01/8/202314:00GLOBEAchieve Life Sciences to Announce Second Quarter 2023..
18/7/202314:00GLOBEAchieve Life Sciences Announces Presentation at 2023..
11/7/202317:23GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..
06/6/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
25/5/202315:00GLOBEAchieve Life Sciences Announces Pricing of $16.5 Million..
23/5/202312:00GLOBEAchieve Life Sciences Reports Statistically Significant..
17/5/202314:00GLOBEAchieve Life Sciences Announces Refinancing of Outstanding..
09/5/202322:05GLOBEAchieve Life Sciences Reports Financial Results for First..

Dernières Valeurs Consultées

NASDAQ
ACHV
Achieve Life Sciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés